Article Text

other Versions

PDF
The implantable defibrillator that predicted the future
  1. Luca De Mattia,
  2. Vittorio Calzolari,
  3. Martino Crosato
  1. Department of Cardiology, Ospedale Civile Ca'Foncello, Treviso, Italy
  1. Correspondence to Dr Luca De Mattia, Department of Cardiology, Ospedale Civile Ca'Foncello, Piazzale Ospedale 1, Treviso 31100, Italy; dmluca.it{at}libero.it

Statistics from Altmetric.com

Clinical introduction

A 69-year-old man with a left-sided, dual-chamber implantable cardioverter defibrillator (ICD) (Atlas+V-243, Tendril 1688T atrial lead and Riata 7040 ventricular lead, St Jude Medical) implanted 7 years before he underwent a routine ICD follow-up visit in May 2014.

He reported one external direct-current electrical cardioversion (ECV) 1 month before for persistent symptomatic atrial fibrillation: one 360 J biphasic shock was delivered through a parasternal and a precordial paddle. Postprocedure ICD interrogation was not performed.

Previous device and lead parameters were unremarkable.

Figure 1A shows ICD battery status, pacing and antitachycardia parameters at the time of device interrogation.

Figure 1

(A) Implantable cardioverter defibrillator parameters summary: pacing (red box: ‘modalità’=pacing mode, ‘frequenza base’=pacing rate, ‘uscita stimolazione’=pacing output) and tachycardia settings (blue box: ‘configurazione zona tachy’=tachy …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles